Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2008

01-01-2008 | Case Report

Phrenic nerve palsy in a patient of Churg Strauss syndrome and mononeuritis multiplex

Authors: Aman Sharma, Pradeep Bambery, Suryanarayana Bettadapura Shamanna, Ajay Wanchu, Surjit Singh

Published in: Clinical Rheumatology | Issue 1/2008

Login to get access

Abstract

Neurological manifestations like mononeuritis multiplex are seen commonly in patients with Churg Strauss syndrome. Cranial nerve involvement and central nervous system involvement are also reported, although infrequently. Phrenic nerve involvement has not been reported so far. We report a patient with Churg Strauss syndrome who presented with mononeuritis multiplex and developed left-sided phrenic nerve palsy subsequently.
Literature
1.
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–100PubMedCrossRef
2.
Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 27:277–301PubMed
3.
Chumbley, LC, Harrison, EG, DeRemee, RA (1975) Allergic granulomatosis and angiitis (Churg Strauss Syndrome). Report of 30 cases. Mayo Clin Proc 52:477–484
4.
Sehgal M, Swanson JW, DeRemee RA, Colby TV (1995) Neurological manifestations of Churg Strauss Syndrome. Mayo Clin Proc 70:337–341PubMedCrossRef
5.
Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia. A clinical approach to Churg Strauss Syndrome. Medicine (Baltimore) 63:65–81
6.
Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P (1999) Churg Strauss Syndrome. Clinical study and long term follow up of 96 patients. Medicine (Baltimore) 78:26–37CrossRef
7.
Hattori N, Ichimura M, Nagamatsu M, Li M, Yamamoto K, Kumazawa K, Mitsuma T, Sobue G (1999) Clinicopathological features of Churg Strauss syndrome associated neuropathy. Brain 122:427–439PubMedCrossRef
8.
Guillevin L, Pagnoux C (2003) When should immunosuppressants be prescribed to treat systemic vasculitides? Intern Med 42:313–317PubMed
9.
Hoi AY, Morand EF (2003) Churg-Strauss syndrome: the use of cyclophosphamide in mononeuritis. Rheumatology (Oxford) 42:390–391CrossRef
10.
Loo KL, Ramachandran R, Chow SK, Goh EM, Yeap SS (2004) Mononeuritis in Churg–Strauss syndrome in Asians responding to intravenous cyclophosphamide. Rheumatology (Oxford) 43:251–252CrossRef
Metadata
Title
Phrenic nerve palsy in a patient of Churg Strauss syndrome and mononeuritis multiplex
Authors
Aman Sharma
Pradeep Bambery
Suryanarayana Bettadapura Shamanna
Ajay Wanchu
Surjit Singh
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0703-1

Other articles of this Issue 1/2008

Clinical Rheumatology 1/2008 Go to the issue

Original Article

Adult onset Still’s disease: a study of 14 cases

Brief Report

Clinical and radiological features of rheumatoid arthritis in British black Africans

Original Article

Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective–descriptive study in north-east of Iran

Case Report

Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin

Original Article

HLA class 1 associations in Henoch Schonlein purpura: increased and decreased frequencies

Case Report

Acute painless monocular visual loss due to central retinal artery occlusion in a patient with Churg–Strauss vasculitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits